| 英文名稱 | Belinostat (Synonyms:PXD101; PX105684) |
|---|---|
| 中文名稱 | 貝利司他 |
| CAS號 | 866323-14-0 |
| 分子式 | C15H14N2O4S |
| 分子量 | 318.35 |
| 外觀 | Off-white crystalline powder |
| 儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| 英文名稱 | Belinostat (Synonyms:PXD101; PX105684) |
|---|---|
| 中文名稱 | 貝利司他 |
| CAS號 | 866323-14-0 |
| 分子式 | C15H14N2O4S |
| 分子量 | 318.35 |
| 外觀 | Off-white crystalline powder |
| 儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity. Belinostat targets HDAC enzymes, thereby inhibiting tumor cell proliferation, inducing apoptosis, promoting cellular differentiation, and inhibiting angiogenesis. This agent may sensitize drug-resistant tumor cells to other antineoplastic agents, possibly through a mechanism involving the down-regulation of thymidylate synthase.